特宝生物
(688278)
| 流通市值：294.40亿 | | | 总市值：294.40亿 |
| 流通股本：4.07亿 | | | 总股本：4.07亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 528,072,404.71 | 371,821,698.43 | 333,254,167.74 | 284,902,844.18 |
| 应收票据及应收账款 | 695,961,143.22 | 808,524,408.19 | 577,913,926.23 | 531,699,741.61 |
| 其中：应收票据 | 41,937,547.98 | 37,027,868.8 | 27,059,360.06 | 70,727,047.56 |
| 应收账款 | 654,023,595.24 | 771,496,539.39 | 550,854,566.17 | 460,972,694.05 |
| 预付款项 | 57,044,322.07 | 38,768,166.49 | 56,880,697.92 | 64,068,072.5 |
| 其他应收款合计 | 30,746,025.01 | 21,976,854.03 | 35,872,420.44 | 31,666,805.88 |
| 存货 | 285,459,731.42 | 263,546,426.51 | 252,749,398.6 | 230,111,701.01 |
| 一年内到期的非流动资产 | 30,739,961.61 | 30,739,961.61 | - | - |
| 其他流动资产 | 1,965,684.73 | 1,748,697.09 | 1,587,135.49 | 1,339,258.28 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,920,029,729.8 | 1,827,090,165.08 | 1,509,551,461.82 | 1,283,654,006.94 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 56,762,884.93 | 56,762,884.93 | 58,035,623.14 | 58,035,033.22 |
| 固定资产 | 505,675,672.1 | 496,526,291.01 | 322,369,811.89 | 316,095,888.4 |
| 在建工程 | 205,692,374.48 | 181,556,607.69 | 304,445,296.16 | 259,971,991.27 |
| 使用权资产 | 8,019,873.39 | 8,672,242.34 | 9,716,112.2 | 10,562,593.76 |
| 无形资产 | 162,616,332.68 | 170,848,518.3 | 179,073,372.45 | 173,827,252.77 |
| 开发支出 | 219,331,253.38 | 208,891,692.66 | 192,881,019.38 | 183,176,125.19 |
| 长期待摊费用 | 16,696,611.14 | 12,308,008.65 | 17,757,977.77 | 19,368,739.09 |
| 递延所得税资产 | 67,153,969.26 | 69,089,875.09 | 42,975,772.92 | 43,883,892.8 |
| 其他非流动资产 | 17,144,935.22 | 18,668,549.83 | 46,509,166.73 | 56,172,559.48 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,259,093,906.58 | 1,223,324,670.5 | 1,173,764,152.64 | 1,121,094,075.98 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,179,123,636.38 | 3,050,414,835.58 | 2,683,315,614.46 | 2,404,748,082.92 |
| 流动负债: | | | | |
| 短期借款 | 9,867,888.89 | - | - | - |
| 应付票据及应付账款 | 56,854,318.01 | 60,140,756.18 | 56,355,580.81 | 30,648,852.06 |
| 应付账款 | 56,854,318.01 | 60,140,756.18 | 56,355,580.81 | 30,648,852.06 |
| 合同负债 | 62,185,572.95 | 63,126,041.07 | 62,140,015.12 | 68,742,405.51 |
| 应付职工薪酬 | 128,557,201.84 | 178,478,291.24 | 131,297,684.32 | 133,586,827.3 |
| 应交税费 | 43,556,634.63 | 69,764,523.07 | 56,117,089.22 | 42,478,832.82 |
| 其他应付款合计 | 39,290,501.47 | 43,327,949.37 | 38,813,361.46 | 34,985,075.42 |
| 一年内到期的非流动负债 | 5,045,358.15 | 5,668,516.94 | 4,452,043.69 | 4,329,054.73 |
| 其他流动负债 | 144,364.65 | 123,387.32 | 126,732.08 | 247,509.56 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 345,501,840.59 | 420,629,465.19 | 349,302,506.7 | 315,018,557.4 |
| 非流动负债: | | | | |
| 租赁负债 | 3,256,774.77 | 3,268,065.07 | 5,450,600.99 | 5,871,596.77 |
| 预计负债 | 39,648,016.18 | 39,305,813.52 | 28,633,447.41 | 31,781,265.02 |
| 递延收益 | 40,555,586.47 | 32,961,392.76 | 34,467,452.68 | 37,571,519.19 |
| 递延所得税负债 | 877,206.61 | 933,807.29 | 913,646.15 | 549,933.39 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 84,337,584.03 | 76,469,078.64 | 69,465,147.23 | 75,774,314.37 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 429,839,424.62 | 497,098,543.83 | 418,767,653.93 | 390,792,871.77 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 406,800,000 | 406,800,000 | 406,800,000 | 406,800,000 |
| 资本公积 | 426,978,680.26 | 413,139,677.14 | 397,824,362 | 397,038,962 |
| 盈余公积 | 182,952,982.18 | 182,952,982.18 | 117,548,442.81 | 117,548,442.81 |
| 未分配利润 | 1,732,552,549.32 | 1,550,423,632.43 | 1,342,375,155.72 | 1,092,567,806.34 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,749,284,211.76 | 2,553,316,291.75 | 2,264,547,960.53 | 2,013,955,211.15 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,749,284,211.76 | 2,553,316,291.75 | 2,264,547,960.53 | 2,013,955,211.15 |
| 负债和股东权益合计 | 3,179,123,636.38 | 3,050,414,835.58 | 2,683,315,614.46 | 2,404,748,082.92 |
| 公告日期 | 2025-04-23 | 2025-03-28 | 2024-10-25 | 2024-08-22 |
| 审计意见(境内) | | 标准无保留意见 | | |